Array Technologies: The Price Is Lagging Solar Peers By Design

Analyst argues Array Technologies (ARRY) is undervalued for long-term clean energy exposure despite recent underperformance. The thesis cites improving backlog and book-to-bill trends, while a conservative DCF still projects revenue at the low end of guidance and margins about 550 bps below the company’s 2026 guidance. Overall, despite acknowledged acquisition/management concerns, the report maintains a 'buy' outlook supported by sector tailwinds and strengthening operating indicators.

Analysis

The market is likely still pricing ARRY as a governance/execution problem rather than a pure cycle story. That matters because if backlog is truly stabilizing, the equity can re-rate quickly: tracker OEMs have high operating leverage once pricing stops bleeding, so even a modest gross-margin recovery can produce outsized EPS revisions. The catch is that this is a competitive market, not a monopoly conversion story; better-run peers can capture the same solar buildout with less valuation skepticism, so ARRY must prove that improvement is durable rather than just a one-quarter order bounce.

The next 1-2 earnings cycles are the critical window. Backlog and book-to-bill are useful only if they translate into realized revenue without further margin giveback; otherwise the stock remains a value trap with a cheap multiple for good reason. The cleanest falsifier is a flat-to-down gross margin trend or another downward guide reset on 2026 economics, which would imply that pricing pressure and acquisition integration costs are still overwhelming volume leverage.

Contrarian angle: consensus may be underestimating how much lower tracker pricing helps developers’ project IRRs and therefore the broader utility-scale solar pipeline. That supports the whole supply chain, but it does not automatically make ARRY the best expression of the theme; NXT likely remains the quality winner, while ARRY is the higher-beta recovery trade. CETY is only a sympathy watch unless it can show funded backlog and commercial traction, which are the real evidence points here.

Key Decisions for Investors

• Initiate a small starter long ARRY only on confirmation of margin stabilization in the next print; treat this as a 3-6 month re-rating trade, not a secular compounder position. Use a hard thesis stop if gross margin or 2026 guidance is cut again.
• Prefer a relative-value long ARRY / short NXT only if the valuation gap remains wide after results and ARRY shows sequential margin improvement. Keep sizing modest: this is a catch-up trade, and NXT's execution premium can persist longer than expected.
• Avoid chasing CETY as a clean-energy beta substitute. Without visible backlog conversion and financing visibility, it is a lower-quality way to express the same theme.
• Set an alert on the next two quarterly gross-margin prints: if the company shows at least a few hundred bps of sequential improvement and backlog holds, the stock can rerate meaningfully; if not, exit the thesis.